Verdad Advisers’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
Other funds holding VERA
KCM
Verdad Advisers's VERA Position: Q3 2026 in Review
Verdad Advisers sold out of Vera Therapeutics (VERA) in Q3 2026, closing a stake of 23,487 shares — an estimated $1.01M sold.
Verdad Advisers first reported a position in VERA in Q1 2026 and held it in 2 quarters. The position peaked at $1.01M in Q2 2026. 224 funds tracked by Wall St. Rank hold VERA as of Q3 2026.
- Verdad Advisers reported no remaining Vera Therapeutics position as of Q3 2026 after selling out during the quarter.
- Verdad Advisers sold 23,487 Vera Therapeutics shares in Q3 2026, an estimated $1.01M.
- Verdad Advisers first reported a position in Vera Therapeutics in Q1 2026 and held it in 2 quarters.
- Verdad Advisers's Vera Therapeutics position peaked at $1.01M in Q2 2026.
- 224 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.
Based on Verdad Advisers's 13F filing for Q3 2026, filed 16 Nov 2026.